跳轉至內容
Merck
全部照片(1)

文件

SML0327

Sigma-Aldrich

AM630

≥90% (HPLC)

同義詞:

6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone, AM 630, Iodopravadoline

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C23H25IN2O3
CAS號碼:
分子量::
504.36
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥90% (HPLC)

形狀

powder

儲存條件

desiccated

顏色

white to beige

溶解度

DMSO: >5 mg/mL

儲存溫度

2-8°C

SMILES 字串

COc1ccc(cc1)C(=O)c2c(C)n(CCN3CCOCC3)c4cc(I)ccc24

InChI

1S/C23H25IN2O3/c1-16-22(23(27)17-3-6-19(28-2)7-4-17)20-8-5-18(24)15-21(20)26(16)10-9-25-11-13-29-14-12-25/h3-8,15H,9-14H2,1-2H3

InChI 密鑰

JHOTYHDSLIUKCJ-UHFFFAOYSA-N

應用

AM630 已被用于:
  • 作为大麻素2(CB2)抑制剂用于研究变色栓菌多糖肽 (TPSP) 的镇痛作用。
  • 作为CB2拮抗剂与β-石竹烯(BCP)一起用于研究其对成纤维细胞再上皮化的作用。
  • 作为CB2拮抗剂用于研究其与原代人成骨细胞中的17-β-雌二醇的相互作用。

生化/生理作用

AM630 是一种选择性 CB2 大麻素拮抗剂/反向激动剂(Ki = 31.2 nM),选择性比CB1 受体大150倍。
AM630是一种氨基烷基吲哚,可作为CP 55,940和WIN 55,212-2的竞争性拮抗剂。它也可作为大麻素和(R)-(+)-花生四烯基-1′-羟基-2′-丙酰胺(AM356)的竞争性拮抗剂。

特點和優勢

《受体分类和信号转导手册》的 大麻素受体页有该化合物的介绍。想要浏览手册的其他页面, 请单击此处

象形圖

Environment

訊號詞

Warning

危險聲明

防範說明

危險分類

Aquatic Acute 1 - Aquatic Chronic 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Francesca Rossi et al.
The Journal of clinical endocrinology and metabolism, 101(9), 3469-3478 (2016-06-14)
Obesity is associated with a low-grade inflammatory state and adipocyte (ADP) hyperplasia/hypertrophy. Obesity inhibits the "browning" of white adipose tissue. Cannabinoid receptor 2 (CB2) agonists reduce food intake and induce antiobesity effect in mice. A common missense CB2 variant, Q63R
Massimo Nabissi et al.
Oncotarget, 7(47), 77543-77557 (2016-10-22)
Several studies showed a potential anti-tumor role for cannabinoids, by modulating cell signaling pathways involved in cancer cell proliferation, chemo-resistance and migration. Cannabidiol (CBD) was previously noted in multiple myeloma (MM), both alone and in synergy with the proteasome inhibitor
Sachiko Koyama et al.
PloS one, 14(12), e0216104-e0216104 (2019-12-17)
Beta-caryophyllene is an odoriferous bicyclic sesquiterpene found in various herbs and spices. Recently, it was found that beta-caryophyllene is a ligand of the cannabinoid receptor 2 (CB2). Activation of CB2 will decrease pain, a major signal for inflammatory responses. We
K A Jenkin et al.
British journal of pharmacology, 173(7), 1128-1142 (2014-12-30)
In diabetic nephropathy agonism of CB2 receptors reduces albuminuria and podocyte loss; however, the role of CB2 receptors in obesity-related nephropathy is unknown. The aim of this study was to determine the role of CB2 receptors in a model of
Marko Hojnik et al.
Biomedical reports, 3(4), 554-558 (2015-07-15)
The bone remodeling process is influenced by various factors, including estrogens and transmitters of the endocannabinoid system. In osteoblasts, cannabinoid receptors 2 (CB-2) are expressed at a much higher level compared to CB-1 receptors. Previous studies have shown that estrogens

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務